Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 12/20 | 0.41 |
| ▸ | CES1 | P23141 | 10/20 | 0.39 |
| ▸ | CES2 | O00748 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25007292 | 0.80 | FAAH (0.42) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL14357445 | 0.79 | FAAH (0.38) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL10254512 | 0.76 | FAAH (0.39) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8651750 | 0.74 | FAAH (0.38) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2892041 | 0.73 | FAAH (0.40) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL16173984 | 0.72 | FAAH (0.36) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL6151160 | 0.72 | FAAH (0.37) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9314915 | 0.70 | FAAH (0.35) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL5970303 | 0.67 | — | — | |
| SCHEMBL458908 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9409843-B2 | Method for producing 1,1,1,5,5,5-hexafluoroacetylacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20160075626-A1 | Method for Producing 1,1,1,5,5,5-Hexafluoroacetylacetone | CENTRAL GLASS COMPANY LIMITED (JP) | 2016-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075626-A1 | Method for Producing 1,1,1,5,5,5-Hexafluoroacetylacetone | TALDO1, HDHD5, AQP1 | FAAH 401/4885CES1 314/4885CES2 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.